AEM
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wick, W. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wick, W. E.
Agricola
Right arrow Articles by Wick, W. E.

 Previous Article  |  Next Article 

Appl Environ Microbiol. 1967 July; 15(4): 765-769
Copyright © 1967 American Society for Microbiology. All Rights Reserved.

Cephalexin, a New Orally Absorbed Cephalosporin Antibiotic

Warren E. Wick

The Lilly Research Laboratories, Indianapolis, Indiana 46206

ABSTRACT

A new antibiotic, structurally related to cephaloglycin, has been assigned the generic name cephalexin, 7-(D-{alpha}-amino-{alpha}-phenylacetamido)-3-methyl-3-cephem-5-carboxylic acid. In vitro antimicrobial activity of cephalexin does not equal that of cephaloglycin. However, excellent oral absorption and lack of serum binding of cephalexin compensates significantly for the lower in vitro activity. Exceptional efficacy against experimental bacterial infections in mice was obtained with cephalexin therapy as compared with cephaloglycin, tetracycline, and chloramphenicol. The data suggest that cephalexin merits clinical trial.


Appl Environ Microbiol. 1967 July; 15(4): 765-769
Copyright © 1967 American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Microbiol. Mol. Biol. Rev. Eukaryot. Cell All ASM Journals

Copyright © 1967 by the American Society for Microbiology. All rights reserved.